|
Volumn 21, Issue 3, 2014, Pages 170-177
|
A comparison of toxicity and health care resource use between eribulin, capecitabine, gemcitabine, and vinorelbine in patients with metastatic breast cancer treated in a community oncology setting
|
Author keywords
capecitabine; Eribulin; gemcitabine; metastatic breast cancer; toxicity; vinorelbine
|
Indexed keywords
ANTIANEMIC AGENT;
ANTIEMETIC AGENT;
BEVACIZUMAB;
CAPECITABINE;
CREATININE;
ERIBULIN;
GEMCITABINE;
GRANULOCYTE COLONY STIMULATING FACTOR;
HEMOGLOBIN;
NAVELBINE;
TRASTUZUMAB;
ANTINEOPLASTIC AGENT;
DEOXYCYTIDINE;
FURAN DERIVATIVE;
KETONE;
VINBLASTINE;
ADULT;
AGED;
ANEMIA;
ARTICLE;
BODY SURFACE;
BODY WEIGHT;
BONE MARROW SUPPRESSION;
BREAST METASTASIS;
CANCER CENTER;
CANCER CHEMOTHERAPY;
CANCER PATIENT;
CHARLSON COMORBIDITY INDEX;
CHEMOTHERAPY INDUCED ANEMIA;
CHEMOTHERAPY INDUCED EMESIS;
COMMUNITY CARE;
COMORBIDITY;
CONTROLLED STUDY;
CREATININE BLOOD LEVEL;
DIARRHEA;
DISEASE FREE INTERVAL;
DRUG DOSE REDUCTION;
DRUG ERUPTION;
DRUG SAFETY;
DRUG WITHDRAWAL;
EDEMA;
FEBRILE NEUTROPENIA;
HAND FOOT SYNDROME;
HEALTH CARE UTILIZATION;
HEMOGLOBIN BLOOD LEVEL;
HUMAN;
LIVER FUNCTION TEST;
MAJOR CLINICAL STUDY;
MULTIPLE CYCLE TREATMENT;
NEUROTOXICITY;
NEUTROPENIA;
NEUTROPHIL COUNT;
OBSERVATIONAL STUDY;
PATIENT SAFETY;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
RETROSPECTIVE STUDY;
SIDE EFFECT;
STOMATITIS;
THROMBOCYTE COUNT;
THROMBOCYTOPENIA;
TREATMENT DURATION;
TREATMENT RESPONSE;
VENOUS THROMBOEMBOLISM;
VOMITING;
ANALOGS AND DERIVATIVES;
BREAST NEOPLASMS;
COMMUNITY MENTAL HEALTH CENTER;
COMPARATIVE STUDY;
FEMALE;
MIDDLE AGED;
ONCOLOGY;
VERY ELDERLY;
ADULT;
AGED;
AGED, 80 AND OVER;
ANTINEOPLASTIC AGENTS;
BREAST NEOPLASMS;
CAPECITABINE;
COMMUNITY MENTAL HEALTH CENTERS;
DEOXYCYTIDINE;
FEMALE;
FURANS;
HUMANS;
KETONES;
MEDICAL ONCOLOGY;
MIDDLE AGED;
RETROSPECTIVE STUDIES;
VINBLASTINE;
|
EID: 84930422579
PISSN: 10781552
EISSN: 1477092X
Source Type: Journal
DOI: 10.1177/1078155214525369 Document Type: Article |
Times cited : (14)
|
References (8)
|